Melatonin (Circadin)

Key facts

Invented name
Circadin
Active substance
melatonin
Therapeutic area
Neurology
Decision number
P/49/2009
PIP number
Melatonin (Circadin)
Pharmaceutical form(s)
Prolonged-release tablet
Condition(s) / indication(s)
Primary insomnia
Route(s) of administration
Oral use
Contact for public enquiries
Applicant: RAD Neurim Pharmaceuticals EEC Ltd
E-mail: talin@neurim.com
Country: Israel
Phone: +972 37684902
Fax: +972 36494568
Decision type
RW: decision refers to a refusal on a request for waiver in all age groups for the listed condition(s)

Decision

Topics

How useful was this page?

Add your rating
Average
1 rating
2 ratings